Barnard-Kelly, Katharine
Whicher, Clare A.
Price, Hermione C.
Phiri, Peter
Rathod, Shanaya
Asher, Carolyn
Peveler, Robert C.
Holt, Richard I. G.
Article History
Received: 29 July 2021
Accepted: 7 December 2021
First Online: 7 January 2022
Declarations
:
: All methods were carried out in accordance with the Declaration of Helsinki, with appropriate ethics approval and participant consent. Ethics approval was received from Health and Care Research Wales ethics board. Informed consent was obtained from all participants prior to participation.
: Consent for publication was given by all participants enrolled in the study. All data is de-identified to protect the anonymity of participants.
: CAW, HCP, PP, CA, SR are employees of Southern Health NHS Foundation Trust. HCP received fees for lecturing, consultancy work and attendance at conferences from Novo Nordisk. KBK received fees for advisory board participation, consultancy work and attendance at conferences from the following: Sanofi, Roche Diabetes Care, Lifescan, Novo Nordisk, Silvercloud, Senseonics. RIGH received fees for lecturing, consultancy work and attendance at conferences from the following: Boehringer Ingelheim, Eli Lilly, Janssen, Lundbeck, Novo Nordisk, Novartis, Otsuka, Sanofi, Sunovion, Takeda, MSD. RCP has no competing interests.